Statement Of Income

Oncolys BioPharma Inc. - Filing #7587326

Concept 2022-01-01 to
2022-09-30
2021-01-01 to
2021-09-30
Statement of income
Statement of income
Net sales
784,509,000 JPY
318,317,000 JPY
Net sales
Operating revenue
Operating expenses
Cost of sales
Cost of sales
474,357,000 JPY
148,936,000 JPY
Selling, general and administrative expenses
1,247,533,000 JPY
1,133,029,000 JPY
Operating profit (loss)
-937,381,000 JPY
-963,649,000 JPY
Non-operating income
Interest income
458,000 JPY
382,000 JPY
Gross profit (loss)
310,152,000 JPY
169,380,000 JPY
Ordinary profit (loss)
-854,455,000 JPY
-976,891,000 JPY
Gross profit
Non-operating income
Non-operating income
100,646,000 JPY
29,703,000 JPY
Financial revenue
Other
40,000 JPY
779,000 JPY
Selling, general and administrative expenses
Non-operating expenses
Interest expenses
3,013,000 JPY
3,191,000 JPY
Non-operating expenses
Extraordinary income
21,406,000 JPY
JPY
Non-operating expenses
Non-operating expenses
17,720,000 JPY
42,945,000 JPY
Financial expenses
Share issuance costs
30,000 JPY
11,007,000 JPY
Other
0 JPY
217,000 JPY
Profit (loss) before income taxes
-833,049,000 JPY
-976,891,000 JPY
Extraordinary income
Income taxes - current
2,199,000 JPY
2,787,000 JPY
Income taxes
2,199,000 JPY
2,787,000 JPY
Profit (loss)
-835,248,000 JPY
-979,679,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.